Literature DB >> 2268260

Stoichiometry and stability of caldesmon in native thin filaments from sheep aorta smooth muscle.

S Marston1.   

Abstract

Ca2(+)-regulated native thin filaments were extracted from sheep aorta smooth muscle. The caldesmon content determined by quantitative gel electrophoresis was 0.06 caldesmon molecule/actin monomer (1 caldesmon molecule per 16.3 actin monomers). Dissociation of caldesmon and tropomyosin from the thin filament and the depolymerization of actin was measured by sedimenting diluted thin filaments. Actin critical concentration was 0.05 microM at 10.1 and 0.13 at 10.05 compared with 0.5 microM for pure F-actin. Tropomyosin was tightly bound, with half-maximal dissociation at less than 0.3 microM thin filaments (actin monomer) under all conditions. Caldesmon dissociation was independent of tropomyosin and not co-operative. The concentration of thin filaments where 50% of the caldesmon was dissociated (CD50) ranged from 0.2 microM (actin monomer) at 10.03 to 8 microM at 10.16 in a 5 mM-MgCl2, pH 7.1, buffer. Mg2+, 25 mM at constant I, increased CD50 4-fold. CD50 was 4-fold greater at 10(-4) M-Ca2+ than at 10(-9) M-Ca2+. Aorta heavy meromyosin (HMM).ADP.Pi complex (2.5 microM excess over thin filaments) strongly antagonized caldesmon dissociation, but skeletal-muscle HMM.ADP.Pi did not. The behaviour of caldesmon in native thin filaments was indistinguishable from caldesmon in reconstituted synthetic thin filaments. The variability of Ca2(+)-sensitivity with conditions observed in thin filament preparations was shown to be related to dissociation of regulatory caldesmon from the thin filament.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268260      PMCID: PMC1149699          DOI: 10.1042/bj2720305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin.

Authors:  A G Weeds; R S Taylor
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

2.  A theory of linear and helical aggregations of macromolecules.

Authors:  F OOSAWA; M KASAI
Journal:  J Mol Biol       Date:  1962-01       Impact factor: 5.469

3.  Purification and properties of Ca2+-regulated thin filaments and F-actin from sheep aorta smooth muscle.

Authors:  S B Marston; C W Smith
Journal:  J Muscle Res Cell Motil       Date:  1984-10       Impact factor: 2.698

4.  Some functional properties of nonpolymerizable and polymerizable tropomyosin.

Authors:  R Dabrowska; E Nowak; W Drabikowski
Journal:  J Muscle Res Cell Motil       Date:  1983-04       Impact factor: 2.698

5.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Chicken gizzard tropomyosin: head-to-tail assembly and interaction with F-actin and troponin.

Authors:  C Sanders; L B Smillie
Journal:  Can J Biochem Cell Biol       Date:  1984-06

7.  Effects of Ca2+ and Mg2+ on the actomyosin adenosine-5'-triphosphatase of stably phosphorylated gizzard myosin.

Authors:  R J Heaslip; S Chacko
Journal:  Biochemistry       Date:  1985-05-21       Impact factor: 3.162

8.  Caldesmon association with smooth muscle thin filaments isolated in the presence and absence of calcium.

Authors:  W Lehman
Journal:  Biochim Biophys Acta       Date:  1986-01-23

9.  Caldesmon is a Ca2+-regulatory component of native smooth-muscle thin filaments.

Authors:  S B Marston; W Lehman
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

10.  The influence of caldesmon on ATPase activity of the skeletal muscle actomyosin and bundling of actin filaments.

Authors:  R Dabrowska; A Goch; B Gałazkiewicz; H Osińska
Journal:  Biochim Biophys Acta       Date:  1985-09-27
View more
  17 in total

1.  A novel Ca2+ binding protein associated with caldesmon in Ca2+-regulated smooth muscle thin filaments: evidence for a structurally altered form of calmodulin.

Authors:  G Notarianni; N Gusev; D Lafitte; T J Hill; H S Cooper; P J Derrick; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

Review 2.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 3.  Actin and the smooth muscle regulatory proteins: a structural perspective.

Authors:  J L Hodgkinson
Journal:  J Muscle Res Cell Motil       Date:  2000-02       Impact factor: 2.698

4.  Novel immunological technique.

Authors:  W Lehman; D Denault; S Marston
Journal:  J Muscle Res Cell Motil       Date:  1992-10       Impact factor: 2.698

5.  Ca(2+)-dependent regulation of vascular smooth-muscle caldesmon by S.100 and related smooth-muscle proteins.

Authors:  K Pritchard; S B Marston
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

6.  Functional interrelationship between calponin and caldesmon.

Authors:  R Makuch; K Birukov; V Shirinsky; R Dabrowska
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

Review 7.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

8.  Modulation of gelsolin-induced actin-filament severing by caldesmon and tropomyosin and the effect of these proteins on the actin activation of myosin Mg(2+)-ATPase activity.

Authors:  R Dabrowska; H Hinssen; B Gałazkiewicz; E Nowak
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Mode of caldesmon binding to smooth muscle thin filament: possible projection of the amino-terminal of caldesmon from native thin filament.

Authors:  E Katayama; M Ikebe
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

10.  Effect of unphosphorylated smooth muscle myosin on caldesmon-mediated regulation of actin filament velocity.

Authors:  K Y Horiuchi; S Chacko
Journal:  J Muscle Res Cell Motil       Date:  1995-02       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.